Swissmedic Guidance: Medicinal Product Name HMV4
Canada Guidance: Regulatory Enrolment Process (REP)
EMA Guidance: Checking process of Mock-ups & Specimens of Outer/Immediate Labelling & PI -CP
UK MHRA: European Commission Decision Reliance Procedure (EC DRP) Extension
USFDA Guidance: Traditional Pre-Market Pathways for COVID Tests
USFDA Guidance: Six Finalized Medical Devices Guidelines
EMA Guidance: Good Practice Guide for the use of the Metadata Catalogue of Real-World Data Sources
MHRA Guidance: Good Clinical Practice for Clinical Trials
USFDA Guidance: Clinical Investigations of Medical Products Involving Children
USFDA Guidance: Electronic Submission Template for Medical Device 510(k) Submissions
USFDA Guidance: Distribution of Approved Naloxone Products -Immediately-in-Effect
Artificial Intelligence in Regulatory Affairs
UK MHRA Guidance: The Northern Ireland MHRA Authorised Route (NIMAR)
USFDA Guide: Updated eCTD 4.0 - TECHNICAL CONFORMANCE GUIDE,
Philippines FDA Guidance: License to Operate (LTO) Application of Retailers of Medical Devices
Swissmedic Guidance: eDok Submission Update
ICH Guidance: Q3D(R2) ELEMENTAL IMPURITIES
Indian Pharmacopoeia Commission (IPC) Joins Pharmacopoeial Discussion Group for Global Expansion
USFDA: Annual Summary Reporting Requirements -Right to Try Act -Final Rule
Health Canada: Udated Register of Innovative Drugs